Searching for trends in recent FTC consent orders and related motions
Shortly after the FTC finalized Nestlé’s consent order, it issued Iovate Health Sciences’ stipulated
final judgment and order for permanent injunctionon July 29, 2010, with the same requirement of “at least two adequate and well-controlled human clinical studies” for any weight-loss-related claims, specifically. (The company was also barred from making disease claims.)
But for bodybuilding-related and other health claims, the FTC did not require a particular number of studies, only stating that "competent and reliable scientific evidence" means “tests, analyses, research, or studies that have been conducted and evaluated in an objective manner by qualified persons and are generally accepted in the profession to yield accurate and reliable results.”
FTC Requirement: At least two human studies (for weight-loss claims, but not for other claims)
<<Previous Next>>
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine jennifer.grebow@ubm.com
Photo © iStockphoto.com/francisblack
FDA revokes authorization to use Red No. 3 as a color additive in food or drugs
January 15th 2025FDA contends that the color additive is safe for humans but is legally obligated by the Delaney Clause of the FD&C act to revoke authorization as research shows the Red No. 3 induces cancer in rats.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.